Detalhe da pesquisa
1.
Salicylates enhance CRM1 inhibitor antitumor activity by induction of S-phase arrest and impairment of DNA-damage repair.
Blood
; 137(4): 513-523, 2021 01 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-33507295
2.
PFKFB3 works on the FAK-STAT3-SOX2 axis to regulate the stemness in MPM.
Br J Cancer
; 127(7): 1352-1364, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35794237
3.
Small Cell Lung Cancer, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology.
J Natl Compr Canc Netw
; 19(12): 1441-1464, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34902832
4.
A Phase II Study of Pazopanib in Patients with Malignant Pleural Mesothelioma: NCCTG N0623 (Alliance).
Oncologist
; 25(6): 523-531, 2020 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-31872928
5.
A phase I study of the VEGFR kinase inhibitor vatalanib in combination with the mTOR inhibitor, everolimus, in patients with advanced solid tumors.
Invest New Drugs
; 38(6): 1755-1762, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-32328844
6.
Phase 1 trial of Vismodegib and Erlotinib combination in metastatic pancreatic cancer.
Pancreatology
; 20(1): 101-109, 2020 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-31787526
7.
Pulmonary Neuroendocrine Tumors: Adjuvant and Systemic Treatments.
Curr Treat Options Oncol
; 21(11): 86, 2020 08 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-32862320
8.
Characterization of Comorbidities Limiting the Recruitment of Patients in Early Phase Clinical Trials.
Oncologist
; 24(1): 96-102, 2019 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30413668
9.
A phase I study of the vascular endothelial growth factor inhibitor Vatalanib in combination with Pemetrexed disodium in patients with advanced solid tumors.
Invest New Drugs
; 37(4): 658-665, 2019 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-30382439
10.
A phase I study of the farnesyltransferase inhibitor Tipifarnib in combination with the epidermal growth factor tyrosine kinase inhibitor Erlotinib in patients with advanced solid tumors.
Invest New Drugs
; 37(2): 307-314, 2019 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-30171497
11.
digit-a tool for detection and identification of genomic interchromosomal translocations.
Nucleic Acids Res
; 45(9): e72, 2017 May 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-28132028
12.
NCCN Guidelines Insights: Small Cell Lung Cancer, Version 2.2018.
J Natl Compr Canc Netw
; 16(10): 1171-1182, 2018 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-30323087
13.
Pembrolizumab versus docetaxel for previously treated, PD-L1-positive, advanced non-small-cell lung cancer (KEYNOTE-010): a randomised controlled trial.
Lancet
; 387(10027): 1540-1550, 2016 Apr 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-26712084
14.
The DNA Methyltransferase DNMT1 and Tyrosine-Protein Kinase KIT Cooperatively Promote Resistance to 5-Aza-2'-deoxycytidine (Decitabine) and Midostaurin (PKC412) in Lung Cancer Cells.
J Biol Chem
; 290(30): 18480-94, 2015 Jul 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-26085088
15.
Comprehensive Genomic Profiling Identifies a Subset of Crizotinib-Responsive ALK-Rearranged Non-Small Cell Lung Cancer Not Detected by Fluorescence In Situ Hybridization.
Oncologist
; 21(6): 762-70, 2016 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-27245569
16.
c-Met expression and MET amplification in malignant pleural mesothelioma.
Ann Diagn Pathol
; 23: 1-7, 2016 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-27402216
17.
Concurrent MCL1 and JUN amplification in pseudomyxoma peritonei: a comprehensive genetic profiling and survival analysis.
J Hum Genet
; 59(3): 124-8, 2014 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-24369359
18.
Phase 1 study of sorafenib in combination with bortezomib in patients with advanced malignancies.
Invest New Drugs
; 31(5): 1201-6, 2013 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-23887852
19.
Phase I dose escalation study of the PKCι inhibitor aurothiomalate for advanced non-small-cell lung cancer, ovarian cancer, and pancreatic cancer.
Anticancer Drugs
; 24(10): 1079-83, 2013 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-23962904
20.
Ectopic expression of VAV1 reveals an unexpected role in pancreatic cancer tumorigenesis.
Cancer Cell
; 7(1): 39-49, 2005 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-15652748